Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-492P (RNA, U6 small nuclear 492, pseudogene) is a human pseudogene, meaning it is a non-functional genomic sequence that shares high similarity with functional genes, in this case, the U6 small nuclear RNA (snRNA)[1][4]. Pseudogenes such as RNU6-492P can sometimes have regulatory roles at the RNA level in rare cases—acting as decoys for microRNAs or competing for binding proteins in certain contexts[2]. However, there is currently no evidence that RNU6-492P itself has any established biological function, serves as a therapeutic target, is implicated as a biomarker, or has any associated safety concerns. The closely related functional gene, U6 snRNA, is an essential component of the spliceosome and mediates pre-mRNA splicing, but RNU6-492P is specifically annotated as a non-functional, likely non-expressed copy[1][4][3].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 492, pseudogene (RNU6-492P).